AI assistant
ERYTECH Pharma S.A. — Regulatory Filings 2021
Apr 7, 2021
1295_dva_2021-04-07_2d05d576-94c5-4d8c-bc42-777ca1869972.pdf
Regulatory Filings
Open in viewerOpens in your device viewer
Monthly information related to total number of voting rights and shares composing the share capital – March 31, 2021.
Article 223-16 of general regulation of French Autorité des Marchés Financiers Lyon – France
Listing markets: Euronext Paris from Euronext (Market segment C - ISIN Code: FR0011471135- Symbol: ERYP) & Nasdaq Global Select Market in the United-States (Symbol : ERYP) Website : www.erytech.com
| Date | Total of shares composing the share capital |
Total of brut (1) voting rights |
Total of net (2) voting rights |
|---|---|---|---|
| December 31, 2020 | 20 057 562 | 21 592 598 |
21 590 098 |
| January 31, 2021 | 20 395 482 | 21 930 518 |
21 928 018 |
| February 28, 2021 | 21 139 668 | 22 668 705 | 22 666 205 |
| March 31, 2021 | 21 619 894 | 23 149 446 | 23 146 946 |
(1) Gross voting rights number (or « theoretical » voting rights) is used as a basis for calculating the crossing of the threshold. In accordance with article 223-11 of general regulation of Autorité des Marchés Financiers, this number is calculated on the basis of all shares carrying the single and double voting rights, including shares without voting rights.
(2) Without treasury shares.